Structural Formula (Sod0o 0000 01)
Sodium Nitroprusside Injection, Solution
Product Images NDC 71288-202
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 71288-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Sod0o 0000 02)
Principal Display Panel – Sodium Nitroprusside Injection, 50 mg Per 2 mL Vial Label (Sod0o 0000 03)
Principal Display Panel – Sodium Nitroprusside Injection, 50 mg Per 2 mL Carton (Sod0o 0000 04)
Sodium Nitroprusside Injection is a potent drug that must be diluted before intravenous infusion only. It comes in 2mL vials which should be stored in the carton and protected from light. Each vial contains Sodium LIS ST RN protect from light. The dilution should be made with natural rubber latex and each 2mL vial of Nitroprusside USP can be diluted in 250mL to 1000mL of % Sodium ?;::euastngmfi;(:sm7rr). The drug's dosage is provided in the package and it is important to monitor blood pressure before and during infusion. The solution should be discarded 24 hours after administration. This drug is not for direct injection and any unused portion must be discarded.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
